Speaker: Assist. Prof. Adil Doganay Duru, NSU Cell Therapy Institute
Venue: A-2, Milkyway seminar room, SciLifeLab, Solna
Host: Adnane Achour, email@example.com
Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer. Parlar A, Sayitoglu EC, Ozkazanc D, Georgoudaki AM, Pamukcu C, Aras M, Josey BJ, Chrobok M, Branecki S, Zahedimaram P, Ikromzoda L, Alici E, Erman B, Duru AD*, Sutlu T*. Eur J Immunol. 2019 Aug;49(8):1278-1290. doi: 10.1002/eji.201948140. Epub 2019 May 17. PubMed PMID: 31054264. *Authors contributed equally
For the first time, a functional TCR complex and MHC-restricted antigen specificity was introduced to NK cells. US patent application #PCT/US2018/012403.
Boosting Natural Killer cells-mediated targeting of sarcoma through DNAM-1 and NKG2D. Sayitoglu EC*, Georgoudaki AM*, Chrobok M*, Josey BJ, Ozkazanc D, Kusser K, Hartman M, Chinn T, Krueger R, Alici E, HT Temple, Sutlu T, Duru AD. (Frontiers in Immunology in press) (* denotes equal contribution)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.